P-glycoprotein (P-gp) is a highly substrate promiscuous efflux transporter that plays a critical role in drug disposition. P-gp utilizes ATP hydrolysis by nucleotide binding domains (NBDs) to drive transitions between inwardfacing (IF) conformations that bind drugs and outward-facing (OF) conformations that release them to the extracellular solution. However, the details of the protein dynamics within either macroscopic IF or OF conformation remain uncharacterized, and the functional role of local dynamics has not been determined. In this work we measured the local dynamics of the IF state of P-gp in lipid nanodiscs and in detergent solution by H/D exchange mass spectrometry. We observed 'EX1 exchange kinetics,' or bimodal kinetics, for several peptides distributed in both NBDs, particularly for P-gp in the lipid nanodiscs. Remarkably, the EX1 kinetics occurred on several time scales, ranging from seconds to hours, suggesting highly complex, and correlated, motions. The results indicate at least three distinct conformational states in the ligand free P-gp and suggest a rough conformational landscape. Addition of excess ATP and vanadate, to favor the OF conformations, caused a generalized, but modest, decrease in H/D exchange throughout the NBDs and slowed the EX1 kinetic transitions of several peptides. The functional implications of the results are consistent with the possibility that conformational selection provides as a source of substrate promiscuity.The membrane transporter P-glycoprotein plays a critical role in disposition and distribution for a wide range of therapeutic drug classes and it is a major determinant of cancer cell drug resistance (1-3). Among the complex properties of P-gp, the mechanisms by which it achieves its extraordinary substrate promiscuity have not been fully understood. P-glycoprotein is a member of the ABC transporter family (ATP Binding Cassette), which includes many structurally related transporters that utilize ATP hydrolysis to transport lipophilic substrates. P-gp includes 12 transmembrane helices (TMHs) that comprise the drug binding site and two NBDs that alternately bind and hydrolyze ATP (4-6). The linear sequence of P-gp includes an N-terminal transmembrane domain containing six TMHs collectively referred to as "transmembrane domain 1" (TMD1), followed by NBD1, a linker region, six additional TMHs, collectively called "transmembrane domain 2" (TMD2), and a second NBD (NBD2). The three dimensional structures of murine and C. elegans orthologs have provided a valuable model for the human Pgp, for which no crystal structure is available ( Figure 1-mouse P-gp structures). The available crystal structures from multiple homologous ABC transporters, including Sav1866 and MsbA (7-9), combined with cryo EM structures, DEER studies with spin-labeled variants, and FRET with fluorescently-labeled NBDs, suggest that P-gp undergoes large scale opening and closing motions, between an inward facing (IF) conformational ensemble and outward-facing (OF) conformational ensemble (1...